Contents

Current Cancer Drug Targets, Volume 2 - Number 1

Prospects for Anti-Neoplastic Therapies Based on Telomere Biology

, 2(1): 1 - 17

sheila A. Stewart and William C. Hahn


DOI: 10.2174/1568009023334015




Diphtheria Fusion Protein Therapy of Chemoresistant Malignancies

, 2(1): 19 - 36

Arthur E. Frankel, Patrick Rossi, Timothy M. Kuzel and Francine Foss


DOI: 10.2174/1568009023333944




Integrins as Novel Drug Targets for Overcoming Innate Drug Resistance

, 2(1): 37 - 43

Jason S. Damiano


DOI: 10.2174/1568009023334033




WT1 as a Novel Target Antigen for Cancer Immunotherapy

, 2(1): 45 - 54

Y. Oka, A. Tsuboi, O. A. Elisseeva, K. Udaka and H. Sugiyama


DOI: 10.2174/1568009023334088




Sulfonamides and Sulfonylated Derivatives as Anticancer Agents

, 2(1): 55 - 75

Angela casini, Andrea Scozzafava, Antonio Mastrolorenzo and Claudiu T. Supuran


DOI: 10.2174/1568009023334060




Receptor Selective Synthetic Retinoids as Potential Cancer Chemotherapy Agents

, 2(1): 77 - 86

D. L. Crowe


DOI: 10.2174/1568009023333935




Author Index To Volume 1

, 2(1): 87

Science Publishers Bentham


DOI: 10.2174/1568009023333980




subject Index To Volume 1

, 2(1): 89

Science Publishers Bentham


DOI: 10.2174/1568009023333953




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science